HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
Background: Hepatocellular carcinoma (HCC) poses a major challenge because of the extreme variability of the clinical outcome, which makes it difficult to properly stage the disease and thereby estimate the prognosis. There is growing evidence that this heterogeneous clinical behavior is attributabl...
Saved in:
Main Authors: | Emilia Fransvea, Angelo Paradiso, Salvatore Antonaci, Gianluigi Giannelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Cellular Oncology |
Online Access: | http://dx.doi.org/10.3233/CLO-2009-0473 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors
by: Francesco Dituri, et al.
Published: (2011-01-01) -
Clinical, genetic aspects and molecular pathogenesis of osteopetrosis
by: D. D. Nadyrshina, et al.
Published: (2023-07-01) -
Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
by: Yulong Wei, et al.
Published: (2021-01-01) -
Molecular Pathogenesis of Cholangiocarcinoma
by: G. Fava, et al.
Published: (2012-01-01) -
Exploring the Molecular Modalities in the Pathogenesis of Diabetic Kidney Disease with a Focus on the Potential Therapeutic Implications
by: Lyubomir Gaydarski, et al.
Published: (2024-12-01)